UBS Downgrades Gartner, Cuts Price Target to $270, Citing Significant Q2 Miss.
ByAinvest
Wednesday, Aug 6, 2025 12:12 pm ET1min read
IT--
UBS now forecasts Gartner's CV growth rate to exit 2025 at 2.5%, down from its previous estimate of 5.1%, and has trimmed its 2026 organic growth forecast to 3% from 6%. The firm attributes the softness to broader cuts in discretionary enterprise spending rather than AI disruption, warning that a recovery may take time. Despite the stock appearing inexpensive on 2026 multiples (12x EBITDA and 16x free cash flow), UBS sees limited near-term upside as growth continues to decelerate through the fourth quarter.
References:
1. [Investing.com](https://www.investing.com/news/stock-market-news/ubs-downgrades-gartner-after-large-q2-miss-slashes-price-target-4174001)
2. [Investing.com](https://www.investing.com/news/analyst-ratings/ubs-downgrades-gartner-stock-to-neutral-on-slowing-contract-value-growth-93CH-4172115)
3. [Investing.com](https://ng.investing.com/news/stock-market-news/ubs-downgrades-gartner-after-large-q2-miss-slashes-price-target-2047391)
UBS downgraded Gartner to Neutral from Buy and cut its price target to $270 from $480 due to a significant miss in Q2 contract value growth. The firm reduced its CV growth trajectory, forecasting a 2.5% growth rate for 2025 and 3% for 2026, citing broader cuts in discretionary enterprise spending rather than AI disruption. The stock appears inexpensive on 2026 multiples but has limited near-term upside as growth decelerates through Q4.
UBS has downgraded Gartner Inc. (NYSE: IT) to Neutral from Buy, slashing its price target from $480 to $270. The move follows a significant miss in the company's second-quarter contract value (CV) growth, which saw an increase of just $8 million, far below UBS's $59 million estimate. This miss led to a 100 basis point cut in the CV growth trajectory.UBS now forecasts Gartner's CV growth rate to exit 2025 at 2.5%, down from its previous estimate of 5.1%, and has trimmed its 2026 organic growth forecast to 3% from 6%. The firm attributes the softness to broader cuts in discretionary enterprise spending rather than AI disruption, warning that a recovery may take time. Despite the stock appearing inexpensive on 2026 multiples (12x EBITDA and 16x free cash flow), UBS sees limited near-term upside as growth continues to decelerate through the fourth quarter.
References:
1. [Investing.com](https://www.investing.com/news/stock-market-news/ubs-downgrades-gartner-after-large-q2-miss-slashes-price-target-4174001)
2. [Investing.com](https://www.investing.com/news/analyst-ratings/ubs-downgrades-gartner-stock-to-neutral-on-slowing-contract-value-growth-93CH-4172115)
3. [Investing.com](https://ng.investing.com/news/stock-market-news/ubs-downgrades-gartner-after-large-q2-miss-slashes-price-target-2047391)

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet